185 related articles for article (PubMed ID: 38427131)
1. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
Rogers JL; Wall T; Acquaye-Mallory AA; Boris L; Kim Y; Aldape K; Quezado MM; Butman JA; Smirniotopoulos JG; Chaudhry H; Tsien CI; Chittiboina P; Zaghloul K; Aboud O; Avgeropoulos NG; Burton EC; Cachia DM; Dixit KS; Drappatz J; Dunbar EM; Forsyth P; Komlodi-Pasztor E; Mandel J; Ozer BH; Lee EQ; Ranjan S; Lukas RV; Raygada M; Salacz ME; Smith-Cohn MA; Snyder J; Soldatos A; Theeler BJ; Widemann BC; Camphausen KA; Heiss JD; Armstrong TS; Gilbert MR; Penas-Prado M
J Neurooncol; 2024 Apr; 167(2):349-359. PubMed ID: 38427131
[TBL] [Abstract][Full Text] [Related]
2. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
[TBL] [Abstract][Full Text] [Related]
3. Conduct of neuro-oncology multidisciplinary team meetings and closing the "gaps" in the clinical management of childhood central nervous system tumors in a middle-income country.
Foo JC; Jawin V; Yap TY; Ahmad Bahuri NF; Ganesan D; Mun KS; Loh J; Azman RR; Gottardo NG; Qaddoumi I; Moreira DC; Rajagopal R
Childs Nerv Syst; 2021 May; 37(5):1573-1580. PubMed ID: 33580355
[TBL] [Abstract][Full Text] [Related]
4. Virtual Clinical and Precision Medicine Tumor Boards-Cloud-Based Platform-Mediated Implementation of Multidisciplinary Reviews Among Oncology Centers in the COVID-19 Era: Protocol for an Observational Study.
Blasi L; Bordonaro R; Serretta V; Piazza D; Firenze A; Gebbia V
JMIR Res Protoc; 2021 Sep; 10(9):e26220. PubMed ID: 34387553
[TBL] [Abstract][Full Text] [Related]
5. Virtual Tumor Board Increases Provider Attendance and Case Presentations.
Davis CH; Ho J; Stephenson R; August DA; Gee H; Weiner J; Alexander HR; Pitt HA; Berger AC
JCO Oncol Pract; 2022 Oct; 18(10):e1603-e1610. PubMed ID: 35939774
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
Koopman B; Groen HJM; Ligtenberg MJL; Grünberg K; Monkhorst K; de Langen AJ; Boelens MC; Paats MS; von der Thüsen JH; Dinjens WNM; Solleveld N; van Wezel T; Gelderblom H; Hendriks LE; Speel EM; Theunissen TE; Kroeze LI; Mehra N; Piet B; van der Wekken AJ; Ter Elst A; Timens W; Willems SM; Meijers RWJ; de Leng WWJ; van Lindert ASR; Radonic T; Hashemi SMS; Heideman DAM; Schuuring E; van Kempen LC
Oncologist; 2021 Aug; 26(8):e1347-e1358. PubMed ID: 33111480
[TBL] [Abstract][Full Text] [Related]
7. The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges.
Ekhator C; Kesari S; Tadipatri R; Fonkem E; Grewal J
Cureus; 2022 Jun; 14(6):e25682. PubMed ID: 35677741
[TBL] [Abstract][Full Text] [Related]
8. Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
Ciliberto G; Canfora M; Terrenato I; Agnoletto C; Agustoni F; Amoroso L; Baldassarre G; Curigliano G; Delmonte A; De Luca A; Fiorentino M; Gregorc V; Ibrahim T; Lazzari C; Mastronuzzi A; Pronzato P; Santoro A; Scambia G; Tommasi S; Vingiani A; Giacomini P; De Maria R
J Exp Clin Cancer Res; 2022 Oct; 41(1):305. PubMed ID: 36245005
[TBL] [Abstract][Full Text] [Related]
9. Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT).
Leeper HE; Tonorezos E; Mayer D; Bakitas M; Chang S; Cooley ME; Hervey-Jumper S; Miaskowski C; Sherwood P; Tsien C; Wallgren K; Willmarth N; Arons D; Acquaye A; King AL; Penas-Prado M; Vera E; Gilbert MR; Armstrong TS;
Neurooncol Adv; 2022; 4(1):vdac029. PubMed ID: 35542753
[TBL] [Abstract][Full Text] [Related]
10. Implementing multidisciplinary tumor boards in oncology: a narrative review.
Mano MS; Çitaku FT; Barach P
Future Oncol; 2022 Jan; 18(3):375-384. PubMed ID: 34787482
[TBL] [Abstract][Full Text] [Related]
11. Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop.
Penas-Prado M; Wu J; Cahill DP; Brat DJ; Costello JF; Kluetz PG; Cairncross JG; van den Bent M; Verhaak RGW; Aboud O; Burger P; Chang SM; Cordova C; Huang RY; Rowe LS; Taphoorn MJB; Gilbert MR; Armstrong TS;
Neurooncol Adv; 2020; 2(1):vdz048. PubMed ID: 33289010
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Cancer care of rural dwellers through telehealth and engagement (ENCORE): protocol to evaluate effectiveness of a multi-level telehealth-based intervention to improve rural cancer care delivery.
Pal T; Hull PC; Koyama T; Lammers P; Martinez D; McArthy J; Schremp E; Tezak A; Washburn A; Whisenant JG; Friedman DL
BMC Cancer; 2021 Nov; 21(1):1262. PubMed ID: 34814868
[TBL] [Abstract][Full Text] [Related]
13. The role of tumor board conferences in neuro-oncology: a nationwide provider survey.
Snyder J; Schultz L; Walbert T
J Neurooncol; 2017 May; 133(1):1-7. PubMed ID: 28421461
[TBL] [Abstract][Full Text] [Related]
14. Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.
Jain NM; Schmalz L; Cann C; Holland A; Osterman T; Lang K; Wiesner GL; Pal T; Lovly C; Stricker T; Micheel C; Balko JM; Johnson DB; Park BH; Iams W
Oncologist; 2021 Nov; 26(11):e1962-e1970. PubMed ID: 34390291
[TBL] [Abstract][Full Text] [Related]
15. ISNO Position Statement on Treatment Guidance in Neuro-oncology During Pandemics.
Gupta T; Singh VP; Balasubramian A; Menon H; Kurkure PA; Kumar S; Jalali R
Neurol India; 2020; 68(4):769-773. PubMed ID: 32859812
[TBL] [Abstract][Full Text] [Related]
16. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.
Engelhardt M; Ihorst G; Schumacher M; Rassner M; Gengenbach L; Möller M; Shoumariyeh K; Neubauer J; Farthmann J; Herget G; Wäsch R
BMC Cancer; 2021 Feb; 21(1):173. PubMed ID: 33596881
[TBL] [Abstract][Full Text] [Related]
18. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer.
Valerio MR; Serretta V; Arico D; Fazio I; Altieri V; Baldari S; Pennisi M; Girlando A; Spada M; Gesolfo CS; Messina M; Messina C; Giorgia L; Sortino G; DI Grazia A; Guggino R; Borsellino N; Piazza D; Gebbia V
Anticancer Res; 2023 Jan; 43(1):501-508. PubMed ID: 36585190
[TBL] [Abstract][Full Text] [Related]
20. Software-Tool Support for Collaborative, Virtual, Multi-Site Molecular Tumor Boards.
Schapranow MP; Borchert F; Bougatf N; Hund H; Eils R
SN Comput Sci; 2023; 4(4):358. PubMed ID: 37131499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
